Available
Project number:
2025_87
Start date:
October 2025
Project themes:
Main supervisor:
Consultant Clinical Oncologist
Co-supervisor:
Professor Andy King
Additional Information:
Multimodal patient data streams to develop an AI-based Pipeline for Multi-Toxicity Predictive Models in Head and Neck Cancer Patients Treated with Radiotherapy
Background
Radiotherapy(RT) is a key curative treatment modality of Head and Neck Cancers(HNC) that, despite technological advances and due to unavoidable irradiation of nearby normal tissues, leads to significant side effects, including permanent debilitating long-term toxicities such as difficulty swallowing, dry mouth or necrosis of the mandible(1). These toxicities are inter-related, with patients experiencing more than one type(2). As such, multi-toxicity prediction models using multimodal data can reflect more accurately the reality and interplay of side effects potentially leading to more effective damage-limiting approaches that are essential in the personalisation of HNC RT.
Novelty & Importance
The novelty of our work resides on developing multi-toxicity prediction models using multi-modal data that also includes spatial information from 3D dose maps. This work will prove a key step in the subsequent development of AI-based adaptive RT protocols to reduce toxicity and improve outcomes.
Aims & Objectives
To develop DL-based multi-toxicity prediction models using clinical, demographic and image-based data(dose maps, annotated CT images).
Planned Research Method
We will evaluate different multimodality fusion strategies of non-imaging (patient, disease, toxicity, DVH) and imaging (dose maps, CT images) data as inputs, assess biases and implement DL intepretability methods to contribute to explainability.
6.Quality Control
We will adhere to TRIPOD guidance(3) and leverage existing national and international collaborations such as the PREDMORN study(4), that our group is leading, to facilitate external evaluation, including making all of our code publicly available to facilitate wide implementation.
References
1. H.P. van der Laan, et al. Impact of radiation-induced toxicities on quality of life of patients treated for head and neck cancer. Radiotherapy and Oncology, 160:47–53, 7 2021
2. A.T.T. Wong et al. Symptom burden and dysphagia associated with osteoradionecrosis in long-term oropharynx cancer survivors: A cohort analysis. Oral Oncology, 66:75–80, 3 2017.
3. Moons KG, et al. Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration. Ann Intern Med. 2015 Jan 6;162(1):W1-73. doi: 10.7326/M14-0698. PMID: 25560730.
4. L. Humbert-Vidan, et al. Protocol letter: A multi-institutional retrospective case-control cohort investigating PREDiction models for Mandibular OsteoRadioNecrosis in head and neck cancer (PREDMORN). In Radiotherapy and Oncology, 176:99-100, 11, November 2022
We are now accepting applications for 1 October 2025
How to apply
Candidates should possess or be expected to achieve a 1st or upper 2nd class degree in a relevant subject including the biosciences, computer science, mathematics, statistics, data science, chemistry, physics, and be enthusiastic about combining their expertise with other disciplines in the field of healthcare.
Important information for International Students:
It is the responsibility of the student to apply for their Student Visa. Please note that the EPSRC DRIVE-Health studentship does not cover the visa application fees or the Immigration Health Surcharge (IHS) required for access to the National Health Service. The IHS is mandatory for anyone entering the UK on a Student Visa and is currently £776 per year for each year of study. Further detail can be found under the International Students tab below.
Next Steps
- Applications submitted by the closing date of Thursday 6 February 2025 will be considered by the CDT. We will contact shortlisted applicants with information about this part of the recruitment process.
- Candidates will be invited to attend an interview. Interviews are projected to take place in April 2025.
- Project selection will be through a panel interview chaired by either Professor Richard Dobson and Professor Vasa Curcin (CDT Directors) followed by informal discussion with prospective supervisors.
- If you have any questions related to the specific project you are applying for, please contact the main supervisor of the project directly.
For any other questions about the recruitment process, please email us at